Is Exosome Therapy Legal? Understanding Research-Use-Only and FDA Status
One of the most important — and most misunderstood — questions about exosomes is their regulatory status. This educational overview explains the key distinctions.
Not FDA-approved as a treatment
In the United States, MSC-derived exosomes are not FDA-approved to diagnose, treat, cure, or prevent any disease. Products of this type are supplied for research use only (RUO).
“FDA-registered facility” is not “FDA-approved”
A facility can register its establishment with the FDA, and a manufacturer can follow a cGMP-aligned process — but neither is the same as FDA approval or endorsement of a product. Credible suppliers state this plainly.
What responsible sourcing looks like
Clear RUO labeling, per-lot documentation, and honest communication that avoids disease-treatment claims. See the published science in our Exosome Research Library.
For clinics and researchers
To source characterized, research-use-only MSC exosomes with full documentation, partner with BioRegenEx.
These statements have not been evaluated by the FDA. BioRegenEx supplies MSC-derived exosomes for research use only (RUO); they are not intended to diagnose, treat, cure, or prevent any disease. This content is educational and is not medical advice.